Susan M. Kelliher - Mar 1, 2023 Form 4/A - Amendment Insider Report for Chemours Co (CC)

Role
SVP, People and Health Service
Signature
/s/ Pauletta Brown, Attorney-in-Fact
Stock symbol
CC
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
3/10/2023, 12:38 PM
Date Of Original Report
Mar 3, 2023
Previous filing
Feb 14, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CC Performance Option (Right to Buy) Award $0 +11.7K $0.00 11.7K Mar 1, 2023 Common Stock 11.7K $38.32 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a 10 percent premium above the closing price of the Company common stock on the date of grant
F2 The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person.
F3 These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.